Robert Way Novartis (NYSE:NVS) said its oral drug iptacopan met the main goal of a phase 3 trial in certain patients with paroxysmal nocturnal hemoglobinuria […]
Tag: Novartis
Novartis radioligand therapy Pluvicto gets approval in EU for advanced prostate cancer
artJazz The European Commission (EC) approved Novartis (NYSE:NVS) Pluvicto to treat certain patients with advanced prostate cancer. The radioligand therapy was approved in combination with […]